Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 ,inter alia, to consider and approve PFA
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shree Ganesh Biotech (India) Ltd has informed the stock exchanges that its Board of Directors will meet on Saturday, 8th November 2025. The main agenda is to consider and approve the unaudited financial results for the quarter and half year ended 30th September 2025. The meeting will also cover any other matters that the Board may decide to take up with its permission. This is a routine regulatory filing under SEBI's Listing Obligations and Disclosure Requirements (Regulation 29), and no financial figures or outcomes have been disclosed yet.
No immediate impact on shareholders or stock price, as this is only an advance notice of a forthcoming board meeting. Investors should watch for the actual Q2/H1 results announcement after 8th November 2025 for any meaningful financial updates.